Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Global Critical Care Therapeutics Market by Drug Class, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Critical Care Therapeutics Market size was estimated at USD 4.54 billion in 2022, USD 4.77 billion in 2023, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.37% to reach USD 6.90 billion by 2030.
In this report, 2018 to 2021 are considered as historical years, 2022 is the base year, 2023 is the estimated year, and years from 2024 to 2030 are considered as the forecast period.
The report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share.
The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Market Segmentation & Coverage:
This research report categorizes the Global Critical Care Therapeutics Market in order to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Drug Class, the market is studied across Albumin, Antithrombin Concentrates, Factor XIII Concentrates, Fibrinogen Concentrates, and Prothrombin Complex Concentrates. The Fibrinogen Concentrates are projected to witness a significant market share during the forecast period.
- Based on Application, the market is studied across Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty, Deep Vein Thrombosis, Hemodialysis, Pulmonary Embolism, and Surgeries. The Deep Vein Thrombosis is projected to witness significant market share during the forecast period.
- The Americas commanded the largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
The report provides insights on the following pointers:
- Market Penetration: Provides comprehensive information on the market offered by the key players
- Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
- Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
- Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
- Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
- Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
Market Dynamics
Drivers
- Rising Geriatric Population Worldwide and Increase in Prevalence of Chronic Diseases: The increasing global geriatric population and the higher prevalence of chronic diseases drive the demand for critical care diagnostics, as these segments require frequent and accurate medical assessment.
- Adoption of Digitization Trends and Illness Due to Sedentary Lifestyle: The adoption of digitization trends and the rise in illnesses resulting from sedentary lifestyles propel the demand for critical care diagnostics, as remote monitoring and early diagnosis become crucial.
- Large Investments in the Healthcare Sector for Modern Medical Treatment Facilities: Significant investments in the healthcare sector to develop modern medical treatment facilities contribute to the growth of critical care diagnostics, as they play an integral role in advanced medical care.
Restraints
- High Cost of Therapeutics: The high cost associated with critical care therapeutics acts as a restraint, impacting the affordability and accessibility of critical care diagnostics for certain segments of the population.
Opportunities
- Government Activities and Support for Implementing Critical Care Diagnostics: Opportunities arise from government initiatives and support aimed at implementing critical care diagnostic technologies, which can lead to enhanced healthcare services and patient outcomes.
- Rising Remote Communications Between Diagnostics and Laboratories: The increasing trend of remote communications and connectivity between diagnostics and laboratories presents opportunities for streamlined data sharing and efficient diagnostic processes.
Challenges
- Lack of Skilled Professionals: The challenge of a shortage of skilled professionals with expertise in critical care diagnostics poses a hurdle to the seamless and effective deployment of these advanced technologies.
Competitive Portfolio:
- Abeona Therapeutics Inc.
- ADMA Biologics, Inc.
- Albumedix Ltd. by Sartorius AG
- Asklepios BioPharmaceutical, Inc.
- Aspen Group
- Bio Products Laboratory Ltd.
- BioDelivery Sciences International, Inc.
- Biotest AG
- CSL Limited
- Grifols SA
- Kedrion Spa
- Novartis AG
- Octapharma AG
- Shanghai RAAS
- Takeda Pharmaceutical Co. Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 184 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $4.77 Billion |
| Forecasted Market Value (USD) by 2030 | $6.9 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/hvljq5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
